Wang Yingliang, He Xuelian, Zhou Chen, Bai Yaowei, Li Tongqiang, Liu Jiacheng, Ju Shuguang, Wang Chaoyang, Xiang Guangya, Xiong Bin
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; Hubei Key Laboratory of Molecular Imaging, Wuhan 430022, China.
School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Acta Biomater. 2022 Dec;154:536-548. doi: 10.1016/j.actbio.2022.09.074. Epub 2022 Oct 12.
Transcatheter arterial chemoembolization (TACE) is extensively used in the treatment of hepatocellular carcinoma (HCC), but its efficacy is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). Herein, we synthesized polyvinyl pyrrolidone (PVP)-coated CaO nanoparticles (CaO NPs) and applied them as a synergistic agent to improve the antitumor efficacy of TACE. After injection into the tumor, CaO NPs reacted with water to generate abundant oxygen, hydroxyl ions (OH), and calcium ions (Ca), thereby relieving tumor hypoxia, neutralizing acid, and overloading Ca to mediate antitumor effects. Moreover, the effect of chemotherapeutic drugs within the TACE was improved due to the modulated TME. CaO NPs efficiently regulated the TME and improved the antitumor effect of doxorubicin under hypoxia conditions in vitro. Compared to other groups, the TACE+CaO NPs group achieved the lowest tumor growth rate, highest tumor necrosis rate, lowest expression of histological markers associated with hypoxia and angiogenesis (HIF-α, VEGF, and CD31), and highest CD8 T cell recruitment in vivo. Thus, these findings demonstrated that CaO NPs provide synergy for TACE therapy in the VX2 orthotopic rabbit liver cancer model, suggesting that they have a potential broad clinical application. STATEMENT OF SIGNIFICANCE: The efficacy of transcatheter arterial chemoembolization (TACE) for treatment of hepatocellular carcinoma is usually limited to secondary tumor hypoxia and other progressive exacerbation of the abnormal tumor microenvironment (TME). To address this issue, we synthesized CaO nanoparticles (CaO NP) which would react with water to generate abundant oxygen, hydroxyl ions (OH), and calcium ions (Ca), thereby relieving tumor hypoxia, neutralizing the acidic TME, and inducing Ca overloading. The efficacy of CaO NPs in combination with TACE was investigated in an orthotopic rabbit liver cancer model, and the results showed the great synergetic antitumor effect of TACE and CaO NPs.
经动脉化疗栓塞术(TACE)广泛应用于肝细胞癌(HCC)的治疗,但其疗效通常局限于继发性肿瘤缺氧以及肿瘤微环境(TME)异常的其他进行性加重。在此,我们合成了聚乙烯吡咯烷酮(PVP)包覆的CaO纳米颗粒(CaO NPs),并将其作为增效剂应用于提高TACE的抗肿瘤疗效。注入肿瘤后,CaO NPs与水反应生成大量氧气、氢氧根离子(OH)和钙离子(Ca),从而缓解肿瘤缺氧、中和酸性并使Ca过载以介导抗肿瘤作用。此外,由于TME得到调节,TACE中化疗药物的效果得到改善。CaO NPs在体外缺氧条件下有效调节TME并提高阿霉素的抗肿瘤效果。与其他组相比,TACE+CaO NPs组在体内实现了最低的肿瘤生长速率、最高的肿瘤坏死率、与缺氧和血管生成相关的组织学标志物(HIF-α、VEGF和CD31)的最低表达以及最高的CD8 T细胞募集。因此,这些发现表明CaO NPs在VX2原位兔肝癌模型中为TACE治疗提供协同作用,表明它们具有潜在的广泛临床应用前景。重要意义声明:经动脉化疗栓塞术(TACE)治疗肝细胞癌的疗效通常局限于继发性肿瘤缺氧以及肿瘤微环境(TME)异常的其他进行性加重。为解决这一问题,我们合成了CaO纳米颗粒(CaO NP),其与水反应生成大量氧气、氢氧根离子(OH)和钙离子(Ca),从而缓解肿瘤缺氧、中和酸性TME并诱导Ca过载。在原位兔肝癌模型中研究了CaO NPs与TACE联合使用的疗效,结果显示TACE和CaO NPs具有强大的协同抗肿瘤作用。